HomeWebcastEmerging Financing Alternatives for Life Sciences Companies: Opportunities and Pitfalls You Need to Know
Online CLE Financing Alternatives for Life Sciences Sector CLE

Emerging Financing Alternatives for Life Sciences Companies: Opportunities and Pitfalls You Need to Know

Live Webcast Date: Friday, October 04, 2019 from 12:00 pm to 1:30 pm (ET)
Finance (CPE)Health Care CLE & CPEPharmaceutical & Life Sciences CLE & CPERecording

Online CLE Financing Alternatives for Life Sciences Sector

Join us for this Knowledge Group Online CLE Financing Alternatives for Life Sciences Sector Webinar. The emergence of real-world data and new digital technologies is fueling growth in the life sciences sector. This trend is resulting to increased investor interest and record funding. In this regard, life sciences businesses are now turning to alternative financing options to fund their growth. These include royalty financing, initial public offerings (IPOs), and collaborative arrangements.

However, companies that enter these types of financing must be wary of potential drawbacks and reporting challenges. They must clearly understand and comply with the updated rules related to these alternatives. Counsel to businesses must develop an advanced strategic approach to leverage potentials and avoid legal issues.

Join a panel of key thought leaders and practitioners assembled by The Knowledge Group as they provide the audience with an in-depth discussion of these financing alternatives for the life sciences industry. Speakers will dig deeper as they analyze critical issues surrounding this topic. They will also offer practical tips and strategies to maximize its potentials in light of the recent regulatory developments.

This Webcast will discuss the following:

  • Life Sciences Funding: Trends and Statistics
  • Financing Alternatives
  • Navigating Potentials
  • Red Flags
  • Risk Mitigation Strategies
  • What Lies Ahead

Agenda

SEGMENT 1:
Laurie A. Burlingame, Partner
Goodwin Procter LLP


I. Introduction

II. Various Alternatives for Raising Capital

  • Traditional Equity 
  • Debt 
  • Government Grants
    • Licensing, Partnerships or Collaborations
  • Royalty transactions 
  • Reg CF (“Crowdfunding”) 
  • Initial Public Offering
  • Form 10
  • Reverse Merger
  • Reg A+ III

III. Preparing for financing

  • Corporate topics to consider for due diligence

SEGMENT 2:
Sara H. Shanti, Partner
Benesch Friedlander Coplan & Aronoff LLP


Regulatory Compliance Considerations

    • Multi-Layered Governance
    • Compliance 101
      • Firm and Executive Liability
    • Data Security and Public Perception
    • Reimbursement and Future Valuation

Market Considerations

    • Trends
    • Value+

Who Should Attend

  • Finance Lawyers and Advisers
  • Finance Executives
  • Accounting Executives
  • Finance Reporting Officers
  • Investment Advisers
  • Biotech, Pharma and Other Life Science Companies

Online CLE Financing Alternatives for Life Sciences Sector

SEGMENT 1:
Laurie A. Burlingame, Partner
Goodwin Procter LLP


I. Introduction

II. Various Alternatives for Raising Capital

  • Traditional Equity 
  • Debt 
  • Government Grants
    • Licensing, Partnerships or Collaborations
  • Royalty transactions 
  • Reg CF (“Crowdfunding”) 
  • Initial Public Offering
  • Form 10
  • Reverse Merger
  • Reg A+ III

III. Preparing for financing

  • Corporate topics to consider for due diligence

SEGMENT 2:
Sara H. Shanti, Partner
Benesch Friedlander Coplan & Aronoff LLP


Regulatory Compliance Considerations

    • Multi-Layered Governance
    • Compliance 101
      • Firm and Executive Liability
    • Data Security and Public Perception
    • Reimbursement and Future Valuation

Market Considerations

    • Trends
    • Value+

Online CLE Financing Alternatives for Life Sciences Sector

Online CLE Financing Alternatives for Life Sciences Sector

Laurie A. BurlingamePartnerGoodwin Procter LLP

Laurie Burlingame is a partner in the firm’s nationally recognized Life Sciences Practice Group. She represents private and public companies across the spectrum of the life sciences industry, including pharmaceuticals, medical devices, diagnostics and biological materials. Ms. Burlingame also represents leading venture capital firms focused on the life sciences industry in connection with their portfolio company investments.

Ms. Burlingame often serves as outside general counsel to her clients, closely advising management teams and boards of directors on a wide variety of matters throughout the company’s life cycle, including formation and founder issues, venture capital financings, public offerings, mergers and acquisitions, licensing transactions, strategic collaborations, commercial transactions, corporate governance and other general corporate matters.

Online CLE Financing Alternatives for Life Sciences Sector

Sara H. ShantiPartnerBenesch Friedlander Coplan & Aronoff LLP

Sara Shanti is a partner in Benesch’s Health Care & Life Sciences Practice Group. Sara represents health care providers and technology companies in matters related to data privacy and security, health care regulatory compliance, and mergers and acquisitions.

Sara’s practice focuses on counseling clients on various digital health matters, including artificial intelligence, breach notification, mobile applications, and telemedicine. Sara’s experience includes advising clients on transferring data across multi-national borders, implementing compliance programs, launching health apps, and responding to federal investigations and security incidents, including ransomeware attacks. Her experience extends to consumer and minor patient rights, medical staff relationships, and transactional matters.


Click Here to Read Additional Material

Online CLE Financing Alternatives for Life Sciences Sector

Course Level:
   Intermediate

Advance Preparation:
   Print and review course materials

Method Of Presentation:
   On-demand Webcast

Prerequisite:
   General knowledge of corporate finance

Course Code:
   148208

NY Category of CLE Credit:
   Areas of Professional Practice

Total Credits:
    1.5 CLE

No Access

You are not logged in. Please or register to the event to gain access to the materials and login instructions.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

Goodwin is a leading Am Law 50 and Global 50 law firm, with offices across the United States and in Europe and Asia. Excelling at complex transactional work and high-stakes litigation, the firm combines in-depth legal knowledge with practical business experience to help clients maximize opportunities and manage risk. With more than 1,000 lawyers, Goodwin offers innovative counsel and delivers results through a client-centric and collaborative approach. The firm focuses on matters involving financial institutions, intellectual property, private equity, real estate capital markets, securities litigation/white collar defense, and technology/life sciences. Information may be found at www.goodwinlaw.com. Follow us on Twitter @goodwinlaw.

Website: https://www.goodwinlaw.com/

Benesch is an AmLaw 200 business law firm and limited liability partnership with offices in Cleveland, Chicago, Columbus, San Francisco, Wilmington, Hackensack and Shanghai. The firm is known for providing highly sophisticated legal services to national and international clients that include public and private, middle market and emerging companies, as well as private equity funds, entrepreneurs, not-for-profit organizations, trusts and estates.

Laurie Burlingame is a partner in the firm’s nationally recognized Life Sciences Practice Group. She represents private and public companies across the spectrum of the life sciences industry, including pharmaceuticals, medical devices, diagnostics and biological materials. Ms. Burlingame also represents leading venture capital firms focused on the life sciences industry in connection with their portfolio company investments.

Ms. Burlingame often serves as outside general counsel to her clients, closely advising management teams and boards of directors on a wide variety of matters throughout the company’s life cycle, including formation and founder issues, venture capital financings, public offerings, mergers and acquisitions, licensing transactions, strategic collaborations, commercial transactions, corporate governance and other general corporate matters.

Sara Shanti is a partner in Benesch’s Health Care & Life Sciences Practice Group. Sara represents health care providers and technology companies in matters related to data privacy and security, health care regulatory compliance, and mergers and acquisitions.

Sara’s practice focuses on counseling clients on various digital health matters, including artificial intelligence, breach notification, mobile applications, and telemedicine. Sara’s experience includes advising clients on transferring data across multi-national borders, implementing compliance programs, launching health apps, and responding to federal investigations and security incidents, including ransomeware attacks. Her experience extends to consumer and minor patient rights, medical staff relationships, and transactional matters.

Ultimate Value Annual Program

Bring a colleague for only $149, a savings of $50 per additional attendee.

  • Unlimited Access to Live & Recorded Webcasts
  • Instant Access to Course Materials
  • And More!

$199